Head-to-head · Value Score
CoreAge Rx vs Alan Meds
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Alan Meds a 74. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameAlan Meds
#164 · Grade C+ · Watch List
Est. first month
From $135/mo (standard dose; microdose tablets from $99)
Save ~90% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 74 — an est. $99/mo first month, with no teaser step-up baked in. Alan Meds isn't out of it: People who specifically want a microdose or an oral tablet, or who want compounded and brand-name options on one account and will check which product a price belongs to.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Alan Meds |
|---|---|---|
| Value Score | 93 (A+) | 74 (C+) |
| Est. first month | $99/mo | From $135/mo (standard dose; microdose tablets from $99) |
| Save vs brand-name | ~89% | ~90% |
| Semaglutide | $99/mo | From $135/mo (standard dose; microdose tablets from $99) |
| Tirzepatide | $149/mo | $325/mo (standard dose; microdose from $145) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | All 50 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Alan Meds
A broad catalog that runs from $99 microdose tablets to $325 standard tirzepatide and brand-name Wegovy - which means the cheapest number on the page is rarely the product you are actually comparing.
Why it's a deal
- Publishes prices for every product rather than gating them behind an intake
- Offers microdose, standard-dose, oral tablet and brand-name routes in one place
- Lists brand Wegovy, Zepbound, Ozempic and Mounjaro alongside compounded options
- Available in all 50 states
The fine print
- The cheapest figures are microdose products, not standard doses - a $99 tablet is not comparable with a standard semaglutide plan
- Standard tirzepatide is $325 a month, well above the cheaper programs here
- The $158 plan is quoted "paid upfront with a 2-month plan", so it is not a month-to-month rate
- Its own asterisk says the actual price depends on the product and plan purchased
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Alan Meds.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.